For
Current canonical position
Should New Zealand ban the use of genetic results in private health/disability/life insurance underwriting?
NO −1000+100 YES
+36
A synthesis of reasoning, not a probability or recommendation.
Probably yes.
The strongest case for a ban is that genetic results are deeply personal, often only partly predictive, and can chill beneficial testing if insurers can use them against people. The main counterargument is adverse selection: insurers say access to some genetic information helps keep premiums fair and markets viable.
Strongest arguments
Against
Recent contributions
Earlier discussions stay here. Open one to continue it.
Anonymous ·
I am a genetic counsellor, and some people don't get genetic testing or delay because of fears of discrimination. This is overall bad for peoples' health as they may not be getting the correct screening or medical care that could lengthen their lives or give better quality of life for longer. Also, many people do have insurance and may not understand that future genetic results are unlikely to alter their cover. They may still avoid or delay genetic testing and these people may end up using more private health care coverage if they end up with a cancer that could have been prevented or detected at an earlier stage, for example.
Moved 4 points toward YES +32 → +36
2 canonical revisions preserved.
Read the full analysis
On balance, the arguments favor banning insurer use of genetic results in underwriting, especially for health and disability cover, because the information is unusually intimate, often uncertain in meaning, and not meaningfully under the applicant’s control. A ban would reduce deterrence to testing and improve privacy and fairness. The best objection is that some use of genetic information may help prevent cross-subsidy and keep private insurance affordable, but that concern is usually weaker than the social cost of discouraging medical genetics and penalizing people for inherited risk.
Important facts
- This is a New Zealand policy issue, and the question concerns private health, disability, and life insurance underwriting rather than public healthcare eligibility.
- Genetic test results can reveal inherited predispositions and familial information that individuals may not regard as fully voluntary or under their control.
- Insurers commonly argue that limiting access to risk-relevant information can increase adverse selection.
- Many genetic results are probabilistic and do not deterministically predict future illness or claims.
- The practical effect of any ban depends on definitions, exceptions, disclosure rules, and whether family history or diagnostic testing is treated the same as predictive genetic testing.
Uncertainties
- How large the premium or availability impact would be in New Zealand if genetic underwriting were banned.
- How much a ban would change incentives to seek genetic testing, counseling, or preventive care.
- Where to draw the line between genetic results, family history, clinical diagnosis, and general medical information.
- Whether the policy would mostly help vulnerable families or mainly shift costs onto other policyholders.
Assumptions
- Inherited risk should generally not be treated the same as voluntary risk-taking for underwriting purposes.
- A functioning private insurance market remains socially valuable, so policy should consider both fairness and insurer solvency.
- The strongest version of the question asks about a general prohibition on use of genetic results in underwriting, not a narrow cap or disclosure threshold.